Magnus Petersson
7PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 13, 2023
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.John W Ostrominski, Muthiah Vaduganathan, Senthil Selvaraj
|Aug 26, 2023
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.Safia Chatur, Muthiah Vaduganathan, Brian L Claggett
|Mar 06, 2023
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.Toru Kondo, Karola S Jering, C Jan Willem Borleffs
|Dec 15, 2022
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial.Orly Vardeny, James C Fang, Akshay S Desai
|Aug 27, 2022
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial.Alexander Peikert, Felipe A Martinez, Muthiah Vaduganathan
|Aug 27, 2022
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.Jawad H Butt, Pardeep S Jhund, Jan Belohlávek
Pageof 2
Frequent Collaborators
7 joint publications
Pardeep S Jhund
7 joint publications
Rudolf A de Boer
7 joint publications
Mikhail N Kosiborod
6 joint publications
Carolyn S P Lam
6 joint publications
John J V McMurray
6 joint publications
Scott D Solomon
5 joint publications
Akshay S Desai
5 joint publications
Adrian F Hernandez
5 joint publications
Felipe Martinez
5 joint publications
Brian L Claggett
